These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17611665)

  • 41. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
    Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
    Abdelhaleem M
    Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
    Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid detection of prognostically important childhood acute lymphoblastic leukemia chimeric transcripts using multiplex SYBR green real-time reverse transcription PCR.
    Ibrahim K; Daud SS; Seah YL; Yeoh AE; Ariffin H;
    Ann Clin Lab Sci; 2008; 38(4):338-43. PubMed ID: 18988926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
    Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
    Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
    Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P
    Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
    Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
    J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
    Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
    Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.